Recurrence of Ewing sarcoma: Is detection by imaging follow‐up protocol associated with survival advantage?
暂无分享,去创建一个
U. Dirksen | M. Weckesser | S. Bielack | H. Gelderblom | L. Stegger | M. Schäfers | T. Simon | H. Jürgens | V. Vieth | S. Bauer | T. Kühne | A. Ranft | H. van den Berg | T. Langer | S. Corbacioglu | W. Hassenpflug | Melina Heinemann | J. Kreyer | Regina Mayer-Steinacker
[1] P. Hari,et al. Effect of Routine Surveillance Imaging on the Outcomes of Patients With Classical Hodgkin Lymphoma After Autologous Hematopoietic Cell Transplantation , 2017, Clinical lymphoma, myeloma & leukemia.
[2] Y. Lee,et al. Comparison of survival outcomes after recurrence detected by cancer antigen 125 elevation versus imaging study in epithelial ovarian cancer , 2016, Journal of gynecologic oncology.
[3] K. S. Hall,et al. Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.
[4] Weidong Yang,et al. From PET/CT to PET/MRI: advances in instrumentation and clinical applications. , 2014, Molecular Pharmaceutics.
[5] U. Dirksen,et al. Cyclophosphamide compared with ifosfamide in consolidation treatment of standard-risk Ewing sarcoma: results of the randomized noninferiority Euro-EWING99-R1 trial. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] U. Dirksen,et al. The value of high‐dose chemotherapy in patients with first relapsed Ewing sarcoma , 2014, Pediatric blood & cancer.
[7] H. Dürr,et al. Nachsorge von Patienten mit Knochensarkomen , 2014, Der Unfallchirurg.
[8] A. Puri,et al. Does Intensity of Surveillance Affect Survival After Surgery for Sarcomas? Results of a Randomized Noninferiority Trial , 2014, Clinical orthopaedics and related research.
[9] Rakesh Kumar,et al. Diagnostic accuracy of 18F-FDG PET/CT for detecting recurrence in patients with primary skeletal Ewing sarcoma , 2013, European Journal of Nuclear Medicine and Molecular Imaging.
[10] J. Healey,et al. Randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma: a report from the Children's Oncology Group. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] U. Dirksen,et al. Risk of recurrence and survival after relapse in patients with Ewing sarcoma , 2011, Pediatric blood & cancer.
[12] Nisa Muangman,et al. Comparison of low dose and standard dose MDCT in detection of metastatic pulmonary nodules. , 2011, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.
[13] T. Kessler,et al. Do patients benefit from routine follow-up to detect recurrences after radical cystectomy and ileal orthotopic bladder substitution? , 2010, European urology.
[14] U. Dirksen,et al. Primary disseminated multifocal Ewing sarcoma: results of the Euro-EWING 99 trial. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] S. Postovsky,et al. Does Regular Follow-up Influence the Survival of Patients With Sarcoma After Recurrence? The Miri Shitrit Pediatric Oncology Department Experience , 2008, Journal of pediatric hematology/oncology.
[16] H. Gerth,et al. Significant Benefit of Multimodal Imaging: PET/CT Compared with PET Alone in Staging and Follow-up of Patients with Ewing Tumors , 2007, Journal of Nuclear Medicine.
[17] S. Postovsky,et al. Positron emission tomography/computed tomography with 18fluoro‐deoxyglucose in the detection of local recurrence and distant metastases of pediatric sarcoma , 2007, Pediatric blood & cancer.
[18] A. Craft,et al. Safety assessment of intensive induction with vincristine, ifosfamide, doxorubicin, and etoposide (VIDE) in the treatment of Ewing tumors in the EURO‐E.W.I.N.G. 99 clinical trial , 2006, Pediatric blood & cancer.
[19] W. Heindel,et al. Tumor staging using whole-body high-resolution 16-channel PET-CT: does additional low-dose chest CT in inspiration improve the detection of solitary pulmonary nodules? , 2006, European Radiology.
[20] R. Grimer,et al. Surveillance in patients with sarcoma of the extremities. , 2005, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[21] S. Bielack,et al. Late effects surveillance system for sarcoma patients , 2004, Pediatric blood & cancer.
[22] A. Alavi,et al. Roles of Positron Emission Tomography With Fluorine-18-Deoxyglucose in the Detection of Local Recurrent and Distant Metastatic Sarcoma , 2003, Clinical nuclear medicine.
[23] U. Göbel,et al. Nachsorge bei Patienten mit Osteosarkom und Ewing-Tumoren : Eine retrospektive Nutzenanalyse , 2000 .
[24] O. Schober,et al. FDG-PET for detection of osseous metastases from malignant primary bone tumours: comparison with bone scintigraphy , 2000, European Journal of Nuclear Medicine.
[25] W. Meyer,et al. MR imaging findings in recurrent primary osseous Ewing sarcoma. , 1994, Magnetic resonance imaging.